Zobrazeno 1 - 10
of 66
pro vyhledávání: '"G I, Gridneva"'
Publikováno v:
Современная ревматология, Vol 18, Iss 3, Pp 128-133 (2024)
Fatigue is a persistent and debilitating feeling of tiredness that limits the ability to perform daily activities and is a common and difficult-to-treat condition in patients with rheumatic diseases (RD). Fatigue is a major challenge for the physicia
Externí odkaz:
https://doaj.org/article/3ff4088712be434980df9cbcc6180e25
Publikováno v:
Современная ревматология, Vol 17, Iss 6, Pp 7-13 (2023)
Over the past two years since the beginning of the COVID-19 pandemic, many patients have experienced symptoms of post-Covid syndrome (PCS), which are often found in rheumatic diseases, which can cause diagnostic difficulties for physicians. The artic
Externí odkaz:
https://doaj.org/article/944d3c67750f4c6e9b95cbadba2294ca
Publikováno v:
Современная ревматология, Vol 17, Iss 6, Pp 72-78 (2023)
Objective: to study the efficacy and safety of the Gam-COVID-Vac vaccine in patients with immunoinflammatory rheumatic diseases (IRD) in a prospective study.Material and methods. The study included 42 patients with IRD and 57 individuals without IRD
Externí odkaz:
https://doaj.org/article/af35124be5be47899fbe1a48f77be5d1
Publikováno v:
Современная ревматология, Vol 17, Iss 5, Pp 67-72 (2023)
Objective: to evaluate the completeness of screening for hepatitis B virus (HBV) infection in HBsAg-positive patients admitted to a rheumatology hospital and to follow the history of HBV reactivation/seroversion during antirheumatic therapy. Material
Externí odkaz:
https://doaj.org/article/8dd816738cab45f7bcb9f2a41fdb28f1
Publikováno v:
Современная ревматология, Vol 17, Iss 4, Pp 71-74 (2023)
Objective: to study the course of COVID -19 and post-covid syndrome (PCS) in patients with rheumatoid arthritis (RA).Material and methods. The study included 32 adult patients with a confirmed diagnosis of RA, who met ACR/EULAR criteria. All patients
Externí odkaz:
https://doaj.org/article/53397b5a35014029b401cebbcd43856a
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 4, Pp 450-457 (2023)
During the three years that have passed since the beginning of the COVID-19 pandemic, many new fundamental and medical problems have been discovered regarding the relationship between the viral infection and many common chronic non- infectious diseas
Externí odkaz:
https://doaj.org/article/7777fa5f1deb4c37be110d8a833a858b
Publikováno v:
Современная ревматология, Vol 17, Iss 3, Pp 89-95 (2023)
Glucocorticoids (GCs) are one of the most commonly used drugs for the treatment of rheumatoid arthritis (RA), the effectiveness of which is beyond doubt. The review considers current literature data on the safety of GCs use, as well as the most commo
Externí odkaz:
https://doaj.org/article/731ab8d81d144e8692a2f16010f8b217
Publikováno v:
Антибиотики и Химиотерапия, Vol 68, Iss 1-2, Pp 69-76 (2023)
The problem of comorbid infections in rheumatology still remains relevant. Against the background of immunosuppressive/immunomodulatory therapy of immuno-inflammatory rheumatic diseases (IIRD), chronic and opportunistic infections (COI) often develop
Externí odkaz:
https://doaj.org/article/de15e106e4634e25bdb449adc3b18a80
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 1, Pp 16-24 (2023)
At the present stage of development of rheumatology, much attention is paid to the problem of comorbid infections, which have a significant impact on mortality and mortality, especially in immuno-inflammatory rheumatic diseases (IIRD). The active int
Externí odkaz:
https://doaj.org/article/2ec7095a64a7436ca46715a44f6c7e49
Publikováno v:
Антибиотики и Химиотерапия, Vol 67, Iss 9-10, Pp 79-89 (2022)
The incidence of pneumocystis pneumonia (PCP) in patients with rheumatic diseases (RD) continues to increase. This is facilitated by the increasing use of genetically engineered biological agents in addition to the use of cytostatics and glucocortico
Externí odkaz:
https://doaj.org/article/a49e632ed1da41f0861504900436a7e9